A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, DOSE RANGING, PARALLEL GROUP STUDY TO EVALUATE THE EFFECT OF GS 6615 ON VENTRICULAR ARRHYTHMIA IN SUBJECTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) OR CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR (CRT-D)

Registry ID

GS-US-356-0101

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

GILEAD SCIENCES CANADA INC

Start date

2015-11-04

Completion date

2016-10-14

Last update

2014-12-18

Conditions

• VENTRICULAR ARRHYTHMIA

Related clinical trials

• STUDY EVALUATING DEXMEDETOMIDINE IN THE ACUTE TREATMENT OF ELECTRICAL STORM (SEDATE)

View on source registry